Shark Tank India: Peyush Bansal invested in a non-invasive glucometer because his pre-diabetic mother is afraid of needles

    A young founder with Type-1 diabetes pitched a non-invasive glucometer won the Shark Tank India judges with her innovation and backstory and earned an offer of Rs. 56 lakhs.

    Shark Tank India: Peyush Bansal invested in a non-invasive glucometer because his pre-diabetic mother is afraid of needles

    Shark Tank India put up a promising display of entrepreneurial acumen and innovation prowess of the country as various start-up owners pitched their products on the show seeking investments by impressing the five ‘sharks’. A particularly moving pitch was presented by Vivalyf innovations for their product EzLyf, a non-invasive glucometer.

    The 20-year-old co-founder Duvvuru Varishtha in her pitch shared her life story with the sharks of how being a type-1 diabetic has pushed her in a coma six times and she has had to prick her finger with a needle four to 4-5 times in a day to keep a check on her sugar level. She shared how she was determined at the age of ten to be able to find a non-invasive solution to check her sugar levels.

    Also read: Shark Tank India: Sippline founder hits back with statistics at Ashneer Grover after being rejected on the show for 'wahiyaat' product

    Duvvuru Varishtha and Vimal Kumar from Hyderbad, the co-founders Vivalyf innovations presented the pitch to sharks, Peyush Bansal, Aman Gupta , Namita Thappar, Ashneer Grover and Anupam Mittal . The young innovator Duvvuru also managed to impress the five judges as she revealed that despite her problems with diabetes she managed to clear all major exams for engineering colleges but dropped out of IIT in 11 days.

    The EzLyf device was then put to test by the sharks which revealed that the product is still at a 90% accuracy level. While sharks like Namita, Aman and Ansheer were unsure about investing, it was shark Peyush Bansal, the CEO of Lenskart and Anupam Mittal, the founder of Shaadi.com who decided to invest in the product which is still of the stage of pre-clinical trials.

    While Duvvuru and Vimal offered the sharks to invest Rs. 56 lakhs in EzLyf for a 7.5% share in equity, Peyush along with Anupam countered the offer matching up the investment amount but with a 33% share in equity. After some discussion this deal was closed but not before Peyush revealed to his follow sharks how his mother in pre-diabetic but refuses to test her sugar levels as she is afraid of pricking herself. He promised to stick to his investment even if the product finally failed to work out.

    Shark Namita Thappar might not have invested but promised to hook up Duvvuru and Vimal with grants and help them connect with hospitals for wider trials of their product.